Self-Adjuvanting Cancer Vaccines from Conjugation-Ready Lipid A Analogues and Synthetic Long Peptides

Niels R. M. Reintjens, Elena Tondini, Ana R. de Jong, Nico J. Meeuwenoord, Fabrizio Chiodo, Evert Peterse, Herman S. Overkleeft, Dmitri V. Filippov, Gijsbert A. van der Marel, Ferry Ossendorp,

Journal of Medicinal Chemistry · 2020 · 37 citations · 35 references

DOIFull text

Open access

Concepts

Abstract

. Synthetic TLR4 ligands thus show great promise in potentiating the conjugate vaccine platform for application in cancer vaccination.

References

35